Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the control of type 2 diabetes. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://macietdfo281473.review-blogger.com/60418937/trelaglutide-exploring-a-new-option-for-chronic-diseases